Data sourcesSEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago
Public companyEntrada Therapeutics, Inc.
TRDACIK 0001689375
Price$4.89
1 year-29.5%
Disclosed transactions8
Buys / sells0 / 5
Max Insider Score24
Connections with evidence5
TRDA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 24 | | TRDAEntrada Therapeutics, Inc. Open-market sale | SELL | $73K 10.5K sh | Aug 6, 2026 | Aug 10, 2026 |
| 23 | | TRDAEntrada Therapeutics, Inc. Open-market sale | SELL | $647K 92.4K sh | Aug 10, 2026 | Aug 10, 2026 traded Aug 10, 2026 | +0d | SEC Form 4 | |
| 23 | | TRDAEntrada Therapeutics, Inc. Open-market sale | SELL | $358K 52.3K sh | Aug 7, 2026 | Aug 10, 2026 traded Aug 7, 2026 | +3d | SEC Form 4 | |
| 9 | RMRadhakrishnan MahaDirector | TRDAEntrada Therapeutics, Inc. Grant or award | A | — 19.0K sh | Jun 10, 2026 | Jun 12, 2026 traded Jun 10, 2026 | +2d | SEC Form 4 | |
| 20 | SNSethuraman NatarajanPresident, Research & Develop. | TRDAEntrada Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $399K 25.9K sh | May 4, 2026 | May 4, 2026 traded May 4, 2026 | +0d | SEC Form 4 | |
| 17 | DJDowden Nathan JPresident & COO | TRDAEntrada Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $230K 15.0K sh | May 4, 2026 | May 4, 2026 traded May 4, 2026 | +0d | SEC Form 4 | |
| 3 | DJDowden Nathan JPresident & COO | TRDAEntrada Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $26K 15.0K sh | May 4, 2026 | May 4, 2026 traded May 4, 2026 | +0d | SEC Form 4 | |
| 7 | DJDowden Nathan JPresident & COO | TRDAEntrada Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 15.0K sh | May 4, 2026 | May 4, 2026 traded May 4, 2026 | +0d | SEC Form 4 | |
President & COO · May 4, 2026